Clinical studies with drugs and biologics aimed at slowing or reversing normal aging processes—emerging results and future perspectives

Five families of investigational products are in clinical investigation to slow or reverse normal aging processes [longevity candidates, mesenchymal stem cells, senolytics drugs, sirtuin activators, and nicotinamide adenine dinucleotide (NAD)+ precursors]. The longevity candidates, vitamin D and met...

Full description

Saved in:
Bibliographic Details
Main Author: Ricardo P. Garay
Format: Article
Language:English
Published: Open Exploration 2024-04-01
Series:Exploration of Drug Science
Subjects:
Online Access:https://www.explorationpub.com/uploads/Article/A100840/100840.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!